Recent Finacing
Recent Raise
Sopherion Therapeutics is a US biotechnology company that holds North American exclusive licensing and plans to launch Myocet (doxorubicin), a first-line metastatic breast cancer therapy combined with cyclophosphamide.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor